Methylation status of uPA promoter as a molecular mechanism regulating prostate cancer invasion and growth in vitro and in vivo

FASEB Journal

Volumn 17, Issue 9, 2003, Pages 1081-1088

  Pakneshan, Pouya ^a   Xing, Rosie Hongmei ^a,b   Rabbani, Shafaat A ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

CpG dinucleotides; MSP; Urokinase plasminogen activator

Indexed keywords

DINUCLEOTIDE; UROKINASE RECEPTOR;

ARTICLE; CANCER INVASION; CPG ISLAND; DNA FLANKING REGION; DNA METHYLATION; DNA SYNTHESIS INHIBITION; ENZYME ACTIVITY; EPITHELIUM CELL; EXTRACELLULAR MATRIX; GENE MUTATION; HUMAN; HUMAN CELL; METHYLATION; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROSTATE EPITHELIUM; TUMOR GROWTH;

ANIMALS; BASE SEQUENCE; BLOTTING, SOUTHERN; CELL DIVISION; CYTOSINE; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); PROSTATE; PROSTATIC NEOPLASMS; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; SULFITES; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR;

EID: 0037709969     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.02-0973com     Document Type: Article

References (37)

1. Rabbani, S. A., and Mazar, A. P. (2001) The role of the plasminogen activation system in angiogenesis and metastasis. Surg. Oncol. Clin. N. Am. 10, 393-415 (x.)
2. Roghani, M., Mohammadi, M., Schlessinger, J., and Moscatelli, D. (1996) Induction of urokinase-type plasminogen activator by fibroblast growth factor (FGF)-2 is dependent on expression of FGF receptors and does not require activation of phospholipase Cgammal. J. Biol. Chem. 271, 31154-31159
3. Vassalli, J. D., and Pepper, M. S. (1994) Tumour biology. Membrane proteases in focus. Nature (London) 370, 14-15
4. Henderson, B. E., Ross, R., and Bernstein, L. (1988) Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation award lecture. Cancer Res. 48, 246-253
5. Grossmann, M. E., Huang, H., and Tindall, D.J. (2001) Androgen receptor signaling in androgen-refractory prostate cancer. J. Natl. Cancer Inst. 93, 1687-1697
6. Denmeade, S. R., and Isaacs, J. T. (2002) A history of prostate cancer treatment. Nat. Rev. Cancer 2, 389-396
7. Hienert, G., Kirchheimer, J. C., Pfluger, H., and Binder, B. R. (1988) Urokinase-type plasminogen activator as a marker for the formation of distant metastases in prostatic carcinomas. J. Urol. 140, 1466-1469
8. Kirchheimer, J., Koller, A., and Binder, B. R. (1984) Isolation and characterization of plasminogen activators from hyperplastic and malignant prostate tissue. Biochim. Biophys. Acta 797, 256-265
9. Duffy, M. J., Duggan, C., Maguire, T., Mulcahy, K., Elvin, P., McDermott, E., Fennelly,J.J., and O'Higgins, N. (1996) Urokinase plasminogen activator as a predictor of aggressive disease in breast cancer. Enzyme Protein 49, 85-93
10. Xing, R, H., and Rabbani, S. A. (1996) Overexpression of urokinase receptor in breast cancer cells results in increased tumor invasion, growth and metastasis. Int. J. Cancer 67, 423-429
11. Xing, R. H., Mazar, A., Henkin, J., and Rabbani, S. A. (1997) Prevention of breast cancer growth, invasion, and metastasis by antiestrogen tamoxifen alone or in combination with urokinase inhibitor B-428. Cancer Res. 57, 3585-3593
12. Rabbani, S. A., and Xing, R. H. (1998) Role of urokinase (uPA) and its receptor (uPAR) in invasion and metastasis of hormonedependent malignancies. Int. J. Oncol. 12, 911-920
13. Bird, A. P. (1986) CpG-rich islands and the function of DNA methylation. Nature (London) 321, 209-213
14. Bird, A. P., and Wolffe, A. P. (1999) Methylation-induced repression-belts, braces, and chromatin. Cell 99, 451-454
15. Ohtani-Fujita, N., Fujita, T., Aoike, A., Osifchin, N. E., Robbins, P. D., and Sakai, T. (1993) CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene. Oncogene 8, 1063-1067
16. Jarrard, D. F., Bova, G. S., Ewing, C. M., Pin, S. S., Nguyen, S. H., Baylin, S. B., Cairns, P., Sidransky, D., Herman, J. G., and Isaacs, W. B. (1997) Deletional, mutational, and methylation analyses of CDKN2 (p16/MTS1) in primary and metastatic prostate cancer. Genes Chromosomes Cancer 19, 90-96
17. Herman, J. G., Latif, F., Weng, Y., Lerman, M. I., Zbar, B., Liu, S., Samid, D., Duan, D. S., Gnarra, J. R., Linehan, W. M., et al. (1994) Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. USA 91, 9700-9704
18. Graff, J. R., Herman, J. G., Lapidus, R. G., Chopra, H., Xu, R., Jarrard, D. F., Isaacs, W. B., Pitha, P. M., Davidson, N. E., and Baylin, S. B. (1995) E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res. 55, 5195-5199
19. Ottaviano, Y. L., Issa, J. P., Parl, F. F., Smith, H. S., Baylin, S. B., and Davidson, N. E. (1994) Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Res. 54, 2552-2555
20. Nakayama, T., Watanabe, M., Suzuki, H., Toyota, M., Sekita, N., Hirokawa, Y., Mizokami, A., Ito, H., Yatani, R., and Shiraishi, T. (2000) Epigenetic regulation of androgen receptor gene expression in human prostate cancers. Lab. Invest. 80, 1789-1796
21. Ahuja, N., Mohan, A. L., Li, Q., Stolker, J. M., Herman J. G., Hamilton, S. R., Baylin, S. B., and Issa, J. P. (1997) Association between CpG island methylation and microsatellite instability in colorectal cancer. Cancer Res. 57, 3370-3374
22. Guo, Y., Higazi, A. A., Arakelian, A., Sachais, B. S., Cines, D., Goldfarb, R. H., Jones, T. R., Kwaan, H., Mazar, A. P., and Rabbani, S. A. (2000) A peptide derived from the nonreceptor binding region of urokinase plasminogen activator (uPA) inhibits tumor progression and angiogenesis and induces tumor cell death in vivo. FASEB J. 14, 1400-1410
23. Guo, Y., Pakneshan, P., Gladu, J., Slack, A., Szyf, M., and Rabbani, S. A. (2002) Regulation of DNA methylation in human breast cancer: effect on the urokinase-type plasminogen activator gene production and tumor invasion. J. Biol. Chem. Aug 26, 10.1074/jbc. M201864200
24. Xing, R. H., and Rabbani, S. A. (1999) Transcriptional regulation of urokinase (uPA) gene expression in breast cancer cells: role of DNA methylation. Int. J. Cancer 81, 443-450
25. Herman, J. G., Graff, J. R., Myohanen, S., Nelkin, B. D., and Baylin, S. B. (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA 93, 9821-9826
26. Verde, P., Boast, S., Franze, A., Robbiati, F., and Blasi, F. (1988) An upstream enhancer and a negative element in the 5′ flanking region of the human urokinase plasminogen activator gene. Nucleic Acids Res. 16, 10699-10716
27. van der Kwast, T. H., Schalken, J., Ruizeveld de Winter, J. A., van Vroonhoven, C. C., Mulder, E., Boersma, W., and Trapman, J. (1991) Androgen receptors in endocrine-therapy-resistant human prostate cancer. Int. J. Cancer 48, 189-193
28. Szyf, M. (1994) DNA methylation properties: consequences for pharmacology. Trends Pharmacol. Sci. 15, 233-238
29. Goelz, S. E., Vogelstein, B., Hamilton, S. R., and Feinberg, A. P. (1985) Hypomethylation of DNA from benign and malignant human colon neoplasms. Science 228, 187-190
30. Jones, P. A., and Laird, P. W. (1999) Cancer epigenetics comes of age. Nat. Genet. 21, 163-167
31. Watt, P. M., Kumar, R., and Kees, U. R. (2000) Promoter demethylation accompanies reactivation of the HOX11 proto-oncogene in leukemia. Genes Chromosomes Cancer 29, 371-377
32. Altschmied, J., Ditzel, L., and Schartl, M. (1997) Hypomethylation of the Xmrk oncogene promoter in melanoma cells of Xiphophorus. Biol. Chem. 378, 1457-1466
33. Feinberg, A. P., and Vogelstein, B. (1983) Hypomethylation of ras oncogenes in primary human cancers. Biochem. Biophys. Res. Commun. 111, 47-54
34. Cannon, R. E., Spalding, J. W., Virgil, K. M., Faircloth, R. S., Humble, M. C., Lacks, G. D., and Tennant, R. W. (1998) Induction of transgene expression in Tg.AC(v-Ha-ras) transgenic mice concomitant with DNA hypomethylation. Mol. Carcinog. 21, 244-250
35. Szyf, M., and Detich, N. (2001) Regulation of the DNA methylation machinery and its role in cellular transformation. Prog. Nucleic Acid Res. Mol. Biol. 69, 47-79
36. Szyf, M. (2002) Utilization of antisense oligonucleotides to study the role of 5-cytosine DNA methyltransferase in cellular transformation and oncogenesis. Methods 27, 184-191
37. Slack, A., Bovenzi, V., Bigey, P., Ivanov, M. A., Ramchandani, S., Bhattacharya, S., TenOever, B., Lamrihi, B., Scherman, D., and Szyf, M. (2002) Antisense MBD2 gene therapy inhibits tumorigenesis. J. Gene Med. 4, 381-389